Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).

Autor: Salhotra A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Aribi A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Ngo D; Department of Clinical Pharmacology, City of Hope National Medical Center, Duarte, California., Zhang J; Department of Information Sciences, City of Hope National Medical Center, Duarte, California., Sandhu K; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Al-Malki M; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Ali H; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Koller P; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Arslan S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Budde E; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Khaled S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Dadwal S; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California., Snyder DS; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Artz A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Forman S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Nakamura R; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Stein A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Marcucci G; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Aldoss I; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California., Pullarkat V; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2021 Jun 01; Vol. 96 (6), pp. E196-E200. Date of Electronic Publication: 2021 Apr 08.
DOI: 10.1002/ajh.26157
Databáze: MEDLINE